Skip to main content
. 2022 Jan 12;18(1):2013693. doi: 10.1080/21645515.2021.2013693

Figure 7.

Figure 7.

Comparison of otitis media (OM) outcomes in children who received PHiD-CV or PCV13.

Leach et al.56 Australian indigenous children aged <36 months who received at least 2 primary doses of PHiD-CV or PCV13. No comparisons between PHiD-CV and PCV13 were statistically significant (p ≥ .07 for all). Lee et al.57 Korean children aged <2 years. All comparisons were statistically significant (p < .05).